If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine.
about
Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice.Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis
P2860
If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
If the treatment works, do we ...... apy for experimental medicine.
@en
If the treatment works, do we ...... apy for experimental medicine.
@nl
type
label
If the treatment works, do we ...... apy for experimental medicine.
@en
If the treatment works, do we ...... apy for experimental medicine.
@nl
prefLabel
If the treatment works, do we ...... apy for experimental medicine.
@en
If the treatment works, do we ...... apy for experimental medicine.
@nl
P2860
P356
P1476
If the treatment works, do we ...... apy for experimental medicine.
@en
P2860
P304
P356
10.1084/JEM.20071737
P407
P577
2007-09-24T00:00:00Z